Berberine is a substituted dibenzo[a,g]quinolizin-7-ium derivative whose modest antibiotic activity is derived from its disruptive impact on the function of the essential bacterial cell division protein FtsZ. The present study reveals that the presence of a biphenyl substituent at either the 2-or 12-position of structurally-related dibenzo[a,g]quinolizin-7-ium derivatives significantly enhances antibacterial potency versus Staphylococcus aureus and Enterococcus faecalis. Studies with purified S. aureus FtsZ demonstrate that both 2-and 12-biphenyl dibenzo[a,g]quinolizin-7-ium derivatives act as enhancers of FtsZ self-polymerization.
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Bacterial resistance to current clinical antibacterial drugs has created a critical need for new therapeutic antibacterial agents with novel targets and modes of action. Infections associated with methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE) represent an increasing nosocomial health concern for both patients and healthcare professionals. 1, 2 FtsZ is a key protein involved in bacterial cell division (cytokinesis). 3, 4 It is highly conserved among bacterial pathogens and, in several genetic studies, has been shown to be indispensable. [5] [6] [7] [8] Cell division in bacteria occurs at the site of formation of a cytokinetic Z-ring polymeric structure, which is comprised of FtsZ subunits. 9 The essential role that FtsZ plays in bacterial cell division makes this protein a promising therapeutic target, and recent advances in the development of small molecules that target FtsZ have been the subject of several recent reviews. [10] [11] [12] [13] FtsZ-targeting antibacterial agents can exert their disruptive effects on the Z-ring by either enhancing or inhibiting FtsZ self-polymerization. [14] [15] [16] [17] [18] [19] [20] [21] Berberine (Fig. 1 ) is a plant alkaloid that exhibits weak antibacterial activity, with MIC values typically on the order of 100-400 lg/mL versus Gram-positive bacteria and >500 lg/mL versus Gram-negative bacteria. [22] [23] [24] Recent studies have suggested that the antibacterial activities of berberine and the structurally-related benzo[c]phenanthridine alkaloid sanguinarine are derived from the inhibitory effects of the compounds on FtsZ polymerization and Z-ring formation. [22] [23] [24] We have recently demonstrated that the presence of phenyl or biphenyl substituents at the 1-or 12-position of substituted 5-methylbenzo[c]phenanthridinium derivatives structurally similar to sanguinarine enhanced relative antibacterial activity versus both S. aureus and E. faecalis (including MRSA and VRE strains). In this study, we explore the effect of aryl substituents at the 2-and the 12-position on the antistaphylo coccal and antienterococcal activities of a series of dibenzo[a,g] quinolizin-7-ium and 8-methyldibenzo[a,g]quinolizin-7-ium derivatives that are structurally-related to berberine.
Two key intermediates were used for the preparation of the 1-substituted dibenzo[a,g]quinolizin-7-ium salts evaluated for antibacterial activity in this study, Table 1 . Commercially available 4-bromo-3-methoxyphenethylamine was treated with 3, 4-dimethoxybenzoylchloride as outlined in Scheme 1 to form N- Berberine Sanguinarine Table 1 .
Both intermediate A and B were subject to Suzuki coupling conditions using various arylboronates (Scheme 2). In the presence of POCl 3 in acetonitrile, these derivatives provided the requisite precursors for the formation of various 7-substituted 3,4-dihydro-1-(3,4-dimethoxybenzyl)isoquinolines. Oxidation in the presence of palladium on carbon in tetralin provided the aromatized 1-benzylisoquinoline derivatives. Treatment of these derivatives with POCl 3 in dimethylformamide yielded the desired 2-substituted 3,4,10,11tetramethoxydibenzo[a,g]quinolizin-7-ium chlorides. Alternatively, treatment of these 1-benzylisoquinoline derivatives with acetic anhydride in the presence of fuming (20%) H 2 SO 4 gave 2substituted 8-methyl-3,4,10,11-tetramethoxydibenzo[a,g]quinolizin-7-ium acetylsulfonates.
The synthesis of 12-aryl substituted dibenzo[a,g]quinolizin-7ium salts was accomplished as outlined in Scheme 3. Treatment of either 2,3-dimethoxyphenethylamine or 3,4-dimethoxyphenethylamine with the acid chloride derivative of 2-bromo-3,4-dimethoxyphenylacetic acid provide the N-
respectively. These bromo derivatives were reacted under Suzuki coupling conditions with several arylboronates, cyclized in the presence of POCl 3 in acetonitrile and oxidized to their respective 1-benzylisoquinoline derivatives. Treatment of these derivatives with POCl 3 in dimethylformamide yielded the desired 12-substituted dibenzo [a,g]quinolizin-7-ium chlorides, 14 and 16. Alternatively, treatment of these 1-benzylisoquinoline derivatives with acetic anhydride in the presence of fuming (20%) H 2 SO 4 gave the 12-substituted 8-methyldibenzo[a,g]quinolizin-7-ium acetylsulfonates, 15 and 17.
These dibenzo[a,g]quinolizin-7-ium derivatives were evaluated for their antibacterial activity against methicillin-sensitive Staphylococcus aureus (MSSA) and methicillin-resistant Staphylococcus aureus (MRSA) as well as vancomycin-sensitive Enterococcus faecalis (VSE) and vancomycin-resistant Enterococcus faecalis (VRE). Their relative antibacterial activities are listed in Table 2 . Berberine did not exhibit appreciable antibiotic activity when evaluated against the strains of S. aureus or E. faecalis used in this study. Compounds 1-4 exhibit significant antibacterial activity against MSSA. The 2-(4-toluyl) derivatives 3 and 4 are more active than the 2-phenyl derivatives 1 and 2 against both S. aureus strains and VSE. The presence or absence of an 8-methyl substituent has a modest effect on antibacterial activity among these trimethoxy derivatives, with this effect being variable and typically reflected by a two-fold difference in MIC values.
Antibacterial activities of the 2-aryl 3,4,10,11-tetramethoxydibenzo[a,g]quinolizin-7-ium derivatives 5-13 were also consistently associated with an increase in antibacterial activity against both S. aureus strains relative to 1 and 2. The effect of an 8-methyl substituent among these tetramethoxy derivatives on antibacterial activity is modest and, in general, tends toward only a slightly greater antibacterial effect. Only in the case of 9 when evaluated against VRE is a slightly greater antibiotic activity observed relative to its 8-methyl derivative, 10.
There was a notable difference between the 3,10,11-trimethoxy-and 3,4,10,11-tetramethoxydibenzo[a,g]quinolizin-7-ium derivatives with regard to activity against E. faecalis. None of the trimethoxy derivatives has an MIC value less than 64 lg/mL against the vancomycin-resistant strain. Interestingly, several of the 2-aryl-3,4,10,11-tetramethoxy derivatives exhibited enhanced activity toward both strains of E. faecalis. The 8-isopropyl derivative, 11, was the most potent dibenzo[a,g]quinolizin-7-ium analog evaluated in both strains of S. aureus and E. faecalis.
Comparison of the antibiotic activities of 9 and 10 with the 1naphthyl derivatives (12,13) and the 12-biphenyl derivatives (14, 15 ) reveals that these compounds exhibit similar activity. The relative antibiotic activities of 14 and 15 tend to be somewhat less than 9 and 10 against the resistant S. aureus and E. faecalis strains. A similar trend is observed in comparing the antibacterial activities of 12-biphenyl-2,3,10,11-trimethoxydibenzo[a,g]quinolizin-7-ium derivatives 16 and 17 with the 2-biphenyl-3,4,10,11-tetramethoxydibenzo[a,g]quinolizin-7-ium derivatives 9 and 10. A 90°-angle light scattering assay was used to monitor the impact, if any, of select dibenzo[a,g]quinolizin-7-ium compounds on the dynamics of self-polymerization by purified S. aureus FtsZ (SaF-tsZ). In this assay, FtsZ polymerization is detected in solution by a time-dependent increase in light scattering. As an illustrative example for a dibenzo[a,g]quinolizin-7-ium compound with an aryl (biphenyl) substitution at the 2-position, Figure 2A shows the time-dependent light scattering profiles of SaFtsZ in the absence and presence of 11 at concentrations of 10 lg/mL and 20 lg/mL. The time-dependent increase in light scattering observed in the presence of vehicle only is reflective of FtsZ selfpolymerization in the absence of test compound. Significantly, the increase in light scattering observed in the presence of 11 is greater than that in the absence of compound, with the extent of this light scattering enhancement being dependent on compound concentration. The lack of light scattering change associated with 20 lg/mL 11 in the absence of FtsZ ( Fig. 2A) confirms that the enhanced light scattering induced by 11 in the presence of FtsZ reflects a corresponding stimulation of FtsZ self-polymerization and not simply compound aggregation or precipitation.
As an illustrative example for the impact on SaFtsZ polymerization of a dibenzo[a,g]quinolizin-7-ium compound with an aryl (biphenyl) substitution at the 12-position, Figure 2B included (at 20 lg/mL) as a control non-FtsZ-targeting antibiotic.
Note that oxacillin exerts a negligible impact on SaFtsZ polymeri-zation, an expected result given that the antibacterial target of oxacillin is the bacterial cell wall rather than FtsZ. A comparison of the light scattering profiles of 11 and 17 at 20 lg/mL (the green profiles in Fig. 2A and B ) reveals the following two differential features: (i) 17 stimulates FtsZ polymerization more rapidly than 11, as reflected by the light scattering profile of 17 reaching a plateau earlier than that of 11. (ii) After reaching a plateau, the light scattering profile of 17 also undergoes a time-dependent decrease, suggestive of a corresponding time-dependent dissociation from larger to smaller FtsZ polymers or polymeric bundles. These two differential features may contribute, at least in part, to the reduced activities of 17 relative to 11 against both the MSSA and MRSA strains tested.
Stimulation of FtsZ polymerization has been shown to be the antibacterial mechanism of action for agents such as the substituted benzamides (e.g., PC190723). 14, 17, 18 In addition, FtsZ has been implicated as the antibacterial target of the naturally occurring dibenzoquinolizinium berberine, although the antibacterial potency of berberine is substantively weaker than that of our substituted dibenzoquinolizinium compounds. 23 Viewed as a whole, the light scattering results point to the stimulation of FtsZ polymerization dynamics as underlying the antibacterial activity of the 2-and 12-substituted dibenzo[a,g]quinolizin-7-ium compounds.
In summary, the presence of an aryl substituent at either the 2-or 12-position of tetramethoxy dibenzoquinolizinium significantly increases FtsZ-targeted antistaphylococcal and antienterococcal activity relative to berberine, with the compounds having notable antibacterial activity against multidrug-resistant strains of both MRSA and VRE. Against VRE, all of the biphenyl-substituted derivatives have MIC values lower than those of the clinical antibiotics used as controls in this study. Studies are in progress to develop suitable formulations for assessment of their relative antibacterial activity in vivo using appropriate animal models of infection. 
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